laboratory assessment of metabolic disorders
TRANSCRIPT
BYPROF. MOUSTAFA RIZK
PROF. OF CLINICAL PATHOLOGYFACULTY OF MEDICINE, UNIVERSITY OF ALEXANDRIA.
Laboratory Assessment Of Metabolic Disorders
10/12/17 06:03
1
Laboratory assessment of disorders of carbohydrates metabolism
10/12/17 06:03
2
When food is ingested there is a parallel rise in blood
glucose level. This increase in blood glucose is
sensed by the ß-cells in the pancreas and as a result,
insulin is secreted.
10/12/17 06:03
3
FROM HYPER TO HYPOGLYC.
10/12/17 06:03
4
Insulin circulates through the body and signals to
the major insulin sensitive organs: muscle, liver
and fat to increase their glucose intake . Insulin
simultaneously leads to a reduction of glucose
production from the liver and other organs . In this
way the hormone insulin counteracts the rise of
glucose in the blood returning the system to its
equilibrium.10/12/17 06:03
5
10/12/17 06:03
6
DIABETES MELLITUS
DEFINITION
Diabetes mellitus is a group of metabolic disorders
of carbohydrate metabolism in which glucose is
underutilized, producing hyperglycemia.
10/12/17 06:03
7
10/12/17 06:03
8
10/12/17 06:03
9
CLASSIFICATION
1.Type 1 DM: autoimmune.
idiopathic.
2. Type 2 DM.
3. Other specific types (2 ry DM):
Acromegaly.
Cortisone treatment.
down’s syndrome
4. Gestational DM.
5. Impaired glucose tolerance.
6. Impaired fasting glucose.10/12/17 06:03
10
10/12/17 06:03
11
CRTERIA OF DIAGNOSIS
Type 2 DM. Classical symptoms of diabetes and RBG> 200 mg/dL. OR
FBG ≥ 126 mg/dL. OR
2 hour OGTT ≥ 200 mg/dL.
Gestational DM:
By OGTT: two out of four criteria :
FBG ≥ 105 mg/dL
1 hour ≥ 190 mg/dL.
2 hour ≥ 165 mg/dL.
3 hour ≥ 145 mg/dL.
10/12/17 06:03
12
Impaired glucose tolerance: Two criteria
FBG < 126 mg/dL
2 h OGTT 140-199 mg/dL.
Impaired fasting glucose: Two criteria
FBG 111-125 mg/dL
2 h OGTT < 140 mg/dL
10/12/17 06:03
13
ROLE OF THE LAB IN DIABETES MELLITUS
I. Diagnosis: Immunological markers:
-Islet cell antibodies (ICA).
-Insulin auto-antibodies ( IAA).
Genetic markers (e.g., HLA).
Insulin secretion.
Blood glucose.
Oral glucose tolerance curve.
Urine ketones.
Others (e.g., C peptide).
10/12/17 06:03
14
II. Management:
Acute:
Glucose ( blood- urine)
Ketones (blood-urine)
Acid-base status (PH, bicarbonate).
Lactate.
Other abnormalities related to cellular dehydration or
therapy ( K, Na, phosphate, osmolality)
10/12/17 06:03
15
Chronic: Glucose (blood-urine)
Glycated proteins(HbA1C-fructosamine)
Urinary protein
Urinary albumin excretion
Proteinuria
Evaluation of complications( renal function, TG, Cholesterol)
Evaluation of pancreas transplant ( C peptide, insulin)
10/12/17 06:03
16
Laboratory assessment of
disorders of Lipids metabolism
10/12/17 06:03
17
18
Major lipids present in plasma:
Fatty Acids Triglycerides Cholesterol Phospholipids
10/12/17 06:03
19
Triglycerides
Normal level < 160 mg/dl
10/12/17 06:03
20
Triglyceride Structure
10/12/17 06:03
21Cholesterol
Normal level < 200 mg / dl
10/12/17 06:03
22
10/12/17 06:03
23
10/12/17 06:03
24
10/12/17 06:03
25
10/12/17 06:03
26
Classification of Lipoproteins
10/12/17 06:03
27
Lipoprotein metabolism
Exogenous TG Chylomicrons(CM)→ Endogenous TG VLDL→ Exogenous Cholesterol CM→ Endogenous Cholesterol LDL→ Reverse Cholesterol Transport
10/12/17 06:03
28
10/12/17 06:03
29
10/12/17 06:03
30
Selection of patients for investigations
CHD & vascular disease Family history of coronary disease Risk factors for CHD Clinical features of hyperlipideamia Lipeamic plasma
10/12/17 06:03
31
Blood sampling for lipid studies
Serum or plasma 12-14 h fasting for TG,HDL & LDL Fasting or no fasting for total cholesterol Usual diet for 2 weeks Avoid vigorous exercise for 1 day
10/12/17 06:03
Serum Cholesterol 140-200 mg/dL Serum Triglycerides: 50-159 mg/dL. HDL-C 35-80 mg/dL
<35 High risk, > 60 Low risk
LDL-C up to 130 mg/dL < 130 Low risk, >160 High risk
HDL/ Total cholesterol >26% Low risk, < 16 % High risk
LDL/HDL > 5% High risk, < 3 % Low risk
Total lipids up to 550 mg/dL.10/12/17 06:03
32
LIPOPROTEIN ELECTROPHORESIS
During electrophoresis, the lipoproteins separate (in order of decreasing mobility) into 4 fractions : alpha, pre-beta, beta lipoproteins and chylomicrons
10/12/17 06:03
33
VALUE OF LIPOGRAM
Increased band Patterns
Chylomicrons I
Beta and pre-beta IIb
Broad beta III
Pre-beta IV
Pre-beta and chylomicrons V
Fredrickson DS. Circulation 1975; 51: 209-211.
10/12/17 06:03
34
Laboratory assessment of some protein disorders
10/12/17 06:03
35
NORMAL PROTEIN BANDS
10/12/17 06:03
36
NORMAL PROTEIN BANDS
Albumin 50-60 %α1 Glob 3 - 5 %α2 Glob 5 - 8 %β Glob 8 -12 %Gamma 12-22 %
10/12/17 06:03 37
PROTEIN DENSITY VERSUS THE CURVE
10/12/17 06:03
38
INCREASED ALPHA GLOBULINS
10/12/17 06:03
39
Patterns of Serum Protein Electrophoresis
Alb A1 A2 B GammaChronic N,D N,E E N E infalmmatoryrespnceAcute N,D E E N N,DinflammatoryrespnceSubacuteN,D N E N N
10/12/17 06:03
40
POLYCLONAL GAMMOPATHY WITH DECREASED ALBUMIN
10/12/17 06:03
41
INCREASED GAMMA GLOBULINS
10/12/17 06:03
42
Patterns of Serum Protein Electrophoresis
Alb A1 A2 B GammaHepatic D N N,D bridging cirrhosisMonoclo N,E N,D N N M spikegammopathyMonoclo N,E N,D N M spike N,DgammopathyBiclonal N,E N,D N M spike M spigammopathy
10/12/17 06:03
43
ACUTE PHASE REACTANTS:
C-reactive protein (CRP). Antiprotease inhibitors. Ceruloplasmin. α1 –acid glycoprotein. Fibrinogen. Haptoglobin. C3.
10/12/17 06:03
44
Negative acute phase reactants:
Albumin. Transferrin.
10/12/17 06:03
45
Laboratory assessment of Mineral and bone metabolism
10/12/17 06:03
46
Minerals important in our body include Minerals important in our body include ::
1- Calcium1- Calcium
2- Phosphorus2- Phosphorus
3- Magnesium3- Magnesium
10/12/17 06:03
47
10/12/17 06:0348
10/12/17 06:0349
11.Parathyroid Hormone:.Parathyroid Hormone:
(A)(A)Synthesis and Secretion :Synthesis and Secretion : PTH is synthesized and secreted by the four PTH is synthesized and secreted by the four
parathyroid glands located on the thyroid parathyroid glands located on the thyroid capsule.capsule.
The conc. of free calcium in blood or extra-The conc. of free calcium in blood or extra-cellular fluid is the primary regulator of PTH cellular fluid is the primary regulator of PTH synthesis and secretion.synthesis and secretion.
Magnesium and 1,25(OH)2 D has a minor Magnesium and 1,25(OH)2 D has a minor influence.influence.
10/12/17 06:03
50
(B) Biological Action :Biological Action : PTH increases total and free Ca++, decreases
plasma Ph and increases urinary excretion of inorganic Ph.
On bones:- PTH stimulates bone resorption or bone
formation.
10/12/17 06:03
51
3) In the kidney, PTH : Increases Ca++ reabsorption in the D.C.T. Decreases reabsorption of Ph by proximal T. Inhibits Na+ - H+ antiporter activity which
favors a mild hypercholermic metabolic acidosis in hyperparathyroid states.
Induces 25-hydroxyvit.D – 1α hydrolase, increasing the production of 1,25(OH)2 D which stimulates intestinal absorption of both Calcium and Phosphate.
10/12/17 06:03
52
10/12/17 06:0353
10/12/17 06:0354
10/12/17 06:03
55
(C) Clinical Significance :(C) Clinical Significance :
Determination of PTH is useful : In the D.D. of both hypocalcaemia &
hypercalcaemia. For assessing parathyroid function in renal
failure. For evaluating parathyroid function in bone
and mineral disorders.
10/12/17 06:03
56
10/12/17 06:0357
22.Vit. D & its metabolites.Vit. D & its metabolites::
(A)(A) Synthesis :Synthesis : Vit. D is produced endogenously by exposure of
skin to sunlight and is absorbed from food.
It is then metabolized to its main circulatory form, 25-hydroxyvit. D and then to its biologically active form, 1,25(OH)2 D which is the hormone regulating calcium and phosphate metabolism.
10/12/17 06:03
58
Vit. D & its metabolitesVit. D & its metabolites
10/12/17 06:03
59
Vit. D & its metabolitesVit. D & its metabolites
(B) Biological Actions of 1,25(OH)(B) Biological Actions of 1,25(OH)2 2 D :D :
Ca and ph. concentrations in serum are maintained by the actions of 1,25(OH)2 D on :
1.intestine.
2.bone.
3. kidney.
4.parathyroid glands.
10/12/17 06:03
60
Vit. D & its metabolitesVit. D & its metabolites
1) In the Intestine :
1,25(OH)2 D stimulates calcium absorption, by the duodenum & phosphate absorption by the jujenum and ileum.
2) On bone :
1,25(OH)2 D increases bone resorption by stimulating osteaclastic differentiation
10/12/17 06:03
61
Vit. D & its metabolitesVit. D & its metabolites
3)In the Kidney 3)In the Kidney ::
It inhibits its own synthesis and stimulates its metabolism.
4)On parathyroid glands 4)On parathyroid glands ::
It inhibits the synthesis and secretion of PTH.
10/12/17 06:03
62
Vit. D & its metabolitesVit. D & its metabolites
(C) Clinical Significance :(C) Clinical Significance :Knowing the concentration of 25(OH)D (which
is the best indication of vit. D nutritional status )because it is:
1.the main circulatory form 2.varies less from day to day with sun exposure &diet 3.easily measuredis useful in evaluating :a) hypocalcaemiab) vit. D statusc) bone diseased) other disorders of mineral metabolism
10/12/17 06:03
63
10/12/17 06:0364
3.CalcitoninCalcitonin:
(A) Secretion:
Calcitonin is secreted by the parafollicular or C cells which are distributed throughout the thyroid glands.
10/12/17 06:03
65
CalcitoninCalcitonin
(B) Biological Actions : Pharmacological doses of calcitonin decrease
serum calcium and ph. concentrations by inhibiting osteoclastic bone resorption.
Multiple forms of Circulating calcitonin have been reported in patients with medullary thyroid carcinomas which occurs as a part of the syndromes of MEN-2A, MEN-2B and familial MTC.
10/12/17 06:03
66
MARKERS OF BONE METABOLISM
MARKERS OF BONE FORMATION 1-OSTEOCALCIN
2-ALKALINE PHOSPHATASE
3-PROCOLLAGEN PEPTIDES
MARKERS OF BONE RESORPTION
1-COLLAGEN CROSS LINKS
2-TARTARATE RESISTENT ACID P
10/12/17 06:03
67
MARKERS OF BONE METABOLISM
3-URINARY GALACTOSYL HYDROXYLYSIN
4-URINARY HYDROXYPROLINE
10/12/17 06:03
68
BONE METABOLIC DISORDERS
OSTEOPOROSIS OSTEOMALACIA PAGETS DISEASE RENAL OSTEODYSTROPHY
10/12/17 06:03
69
Paget’s disease
Paget’s (pronounced paj-ets) disease affects bones. Throughout a person’s life bone is constantly breaking
down and growing back. With Paget’s disease the normal process of bone growth is changed. The bone breaks down more quickly, and when it grows again it is softer than normal bone.
Soft bones can bend or break more easily. The area affected by Paget’s disease can become shorter because the bone bends.
With Paget’s disease the bone can also grow larger than before.
Paget’s disease can affect any bone, but usually affects the skull, the hip and pelvis bones and bones in the legs and back.
10/12/17 06:03
70
Lab Studies
Biochemical indices reveal elevated alkaline phosphatase levels of bone origin, due to increased osteoblastic activity and bone formation.
In limited Paget disease, the alkaline phosphatase level may be within the reference range. Procollagen I N-terminal peptide (PINP) recently has emerged as a sensitive serum marker for bone formation.
Many patients with elevated alkaline phosphatase levels have been found to have osteocalcin measurements within the reference range.
10/12/17 06:03
71
In Paget disease, urinary hydroxyproline levels are elevated as they reflect increased osteoclastic activity and bone resorption.
10/12/17 06:03
72
THANK YOU PROF./MOUSTAFA RIZK
10/12/17 06:03
73